Sign in
8-K

Current Report

Stoke Therapeutics, Inc. Filed Acc 0001193125-24-080874

Material agreement · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d807060d8k.htm…